All stock lists
PepGen Inc. (NASDAQ:PEPG)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
5.48+3.09 (+129.28%)
Market cap
$379M
Insider Score
Health Score
Analyst consensus
Listed since
May 6, 2022
Website
Insider Score
––Not scored
PEPG Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Fair
From PEPG’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars
Profitability—
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$73.3M
- Net margin
- —
Leverage18 / 20
Little or no net debt.
- Total debt
- $15.6M
- Cash
- $22.0M
- Debt / equity
- 0.15
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $107.6M
- Current liabilities
- $12.4M
- Current ratio
- 8.70
Cash generation3 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$63.3M
- Free cash flow
- -$63.3M
Dilution & runway0 / 20
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 69.3M
- Share growth (1y)
- 111.5%
- Cash runway
- 4 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
PEPG Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 319.00 K | 1.06 M | 339.00 K | 0.00 |
| Gross Profit | 0.00 | 0.00 | -319.00 K | -1.06 M | -339.00 K | 0.00 |
| SG&A Expense | 5.91 M | 6.42 M | 5.94 M | 5.85 M | 5.23 M | 5.54 M |
| R&D Expense | 14.48 M | 12.52 M | 12.69 M | 14.19 M | 13.08 M | 18.39 M |
| Operating Expenses | 20.38 M | 18.94 M | 18.62 M | 18.65 M | 18.32 M | 23.93 M |
| Operating Income | 0.00 | -18.94 M | -18.94 M | -19.70 M | -18.65 M | -23.93 M |
| Pretax Income | -19.38 M | -17.80 M | -17.75 M | -18.29 M | -18.03 M | -23.09 M |
| Tax Provision | -13.00 K | 16.00 K | 0.00 | 49.00 K | 0.00 | 0.00 |
| Net Income | -19.39 M | -17.81 M | -17.76 M | -18.34 M | -18.03 M | -23.09 M |
| EPS (Basic) | -0.28 | -0.26 | -0.26 | -0.43 | -0.55 | -0.70 |
| EPS (Diluted) | -0.28 | -0.26 | -0.26 | -0.43 | -0.55 | -0.70 |
| Shares Outstanding | 69.26 M | 69.20 M | 69.09 M | 42.22 M | 32.75 M | 32.75 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.